| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.004 | 1 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.003 | 1 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.0039 | 1 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.0077 | 1 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |